ArticleAmerican journal of respiratory and critical care medicine2023

CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPD.

Cheng-Yu Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.